Novocure is a global, commercial-stage oncology company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields, with the use of electric fields. Novocure is headquartered in Jersey Isle, and operates in Portsmouth, NH and New York, NY. The company also has offices in Switzerland, Germany and Japan, and a research center in Haifa, Israel.
TTFields disrupt cell division through physical interactions with key molecules during mitosis. This non-invasive treatment targets solid tumors.
(via the Novocure website @ http://www.novocure.com/our-therapy.aspx)
Mechanism of Action
Tumor Treating Fields, or TTFields, are low intensity, alternating electric fields within the intermediate frequency range. TTFields disrupt cell division through physical interactions with key molecules during mitosis. This non-invasive treatment targets solid tumors.
Delivery Method
TTFields are generated via pairs of transducers arrays placed directly on the skin’s surface in the region surrounding the tumor. The delivery system is portable and is designed to allow patients to go about their daily activities while receiving treatment.
To get more information and view videos on Novocure’s TTFields Therapy, visit http://www.novocure.com/our-therapy.aspx.
)
Mechanism of Action
Tumor Treating Fields, or TTFields, are low intensity, alternating electric fields within the intermediate frequency range. TTFields disrupt cell division through physical interactions with key molecules during mitosis. This non-invasive treatment targets solid tumors.
Delivery Method
TTFields are generated via pairs of transducers arrays placed directly on the skin’s surface in the region surrounding the tumor. The delivery system is portable and is designed to allow patients to go about their daily activities while receiving treatment.
To get more information and view videos on Novocure’s TTFields Therapy, visit http://www.novocure.com/our-therapy.aspx.